The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) asked CRA to evaluate the policies that host governments of middle-income countries use to encourage investment in innovative activities and the implications for future innovation. CRA consultants looked at eight countries and concluded that there are six key lessons that appear to be critical for success. Read more in the article here:
COVID impact on MedTech priorities
CRA surveyed 36 MedTech leaders to understand their strategic priorities and the impact of COVID-19 on their business. Survey respondents work in leadership...